Advertisement

Topics

Asia Executives To Watch: Novartis China, GSK India, Cipla

06:05 EDT 5 Sep 2017 | SCRIP

Novartis’s former head of West China is moving to lead its global cardio-metabolic franchise, while GSK India and Cipla have...

      

Related Stories

 

Original Article: Asia Executives To Watch: Novartis China, GSK India, Cipla

NEXT ARTICLE

More From BioPortfolio on "Asia Executives To Watch: Novartis China, GSK India, Cipla"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...